Upon entering an age of global ivermectin-based integrated mass drug administration for neglected tropical diseases and malaria

Abstract

Abstract Ivermectin mass drug administration (MDA) in humans to reduce malaria vectors is yet another use for this remarkable medicine whose discoverers shared the 2015 Nobel Prize in Medicine with the discoverer of artemisinin. The malaria community should join those who have long used ivermectin MDA in an integrated battle to break transmission of three vector-borne parasitic diseases.

Keywords

• Malaria
• Ivermectin
• Albendazole
• Lymphatic Filariasis
• Mass Drug Administration